Xarelto, a medication used to prevent blood clots, has faced ongoing patent challenges as companies seek to introduce generic versions. The U.S. Food and Drug Administration (FDA) has approved several generic versions of rivaroxaban, the active ingredient in Xarelto.
When Will Generic Xarelto Be Available?
The availability of generic Xarelto has been a subject of legal disputes and patent expirations. While some generic versions have received FDA approval, their market entry has been subject to ongoing patent litigation. Information regarding specific patent expiries and the exact timing of generic availability can be found through resources like DrugPatentWatch.com [1].
Who Makes Generic Xarelto?
Several pharmaceutical companies have developed and received FDA approval for generic versions of rivaroxaban. These include companies like Micro Labs and Cipla. The landscape of generic manufacturers can change as new approvals are granted and existing ones are challenged.
What is the Difference Between Xarelto and its Generic Versions?
Generic versions of Xarelto contain the same active ingredient, rivaroxaban, and are required to be bioequivalent to the brand-name drug. This means they should have the same dosage, form, safety, strength, and route of administration. The primary difference typically lies in the inactive ingredients, which do not affect how the drug works.
Why Are Companies Challenging Xarelto's Patents?
Companies challenge patents on drugs like Xarelto to pave the way for the introduction of their generic versions. Successful patent challenges can lead to earlier market entry for generics, often resulting in lower drug prices for consumers. These challenges are a common part of the pharmaceutical market, as generic manufacturers aim to compete with brand-name drugs once their exclusivity periods end or are invalidated.
What Are the Risks of Generic Drugs?
Generic drugs are held to the same rigorous standards of safety and efficacy as brand-name drugs by regulatory bodies like the FDA. The FDA ensures that generic drugs are bioequivalent to their brand-name counterparts. Therefore, the risks associated with generic Xarelto are generally considered to be the same as those associated with the brand-name drug, provided the generic is FDA-approved [2].
How Much Does Generic Xarelto Cost?
Generic medications typically cost significantly less than their brand-name counterparts. Once generic Xarelto becomes widely available without significant legal barriers, its price is expected to be considerably lower than the cost of prescription Xarelto.
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.fda.gov/